Journal Guide

Fitoterapia is a Journal dedicated to medicinal plants and to bioactive natural products of plant origin. It publishes original contributions in seven major areas:1. Characterization of active ingredients of medicinal plants2. Development of standardization method for bioactive plant extracts and natural products3. Identification of bioactivity in plant extracts4. Identification of targets and mechanism of activity of plant extracts5. Production and genomic characterization of medicinal plants biomass6. Chemistry and biochemistry of bioactive natural products of plant origin7. Critical reviews of the historical, clinical and legal status of medicinal plants, and accounts on topical issues.Contributions reporting the following are not normally considered for publication:1. Activity data on crude extracts that have not been characterized by analysis of their major constituents (HPLC, NMR);2. Unexceptional and predictable bioactivity (e.g. antioxidant properties of phenolics or antibacterial activity of essential oils);3. Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded.The following immediate rejection criteria apply:RULE 1: The manuscript does not fall into any of the areas of interest of the Journal;RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control;RULE 3: The botanical source is not clearly identified, authenticated, and documented (voucher);RULE 4: Bioactivity is not relevant to in vivo situations.The journal encourages Authors to enhance the description of their methodological procedures by submitting accompanying multimedia files (video or animation sequences). These files are to be submitted as supplementary material, see below.The journal publishes supplements, podcasts and webinars. For sponsorship opportunities please contact a.pordon@elsevier.com.

Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including:

Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a monthly point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research, from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.

C. elegans RDE-4 is a double-stranded RNA binding protein that has been shown to play a key role in response to foreign double-stranded RNA (dsRNA). We have used diverse tools for analysis of gene function to characterize the domain and organismal foci of RDE-4 action in C. elegans. First, we examined the focus of activity within the RDE-4 protein, by testing a series of RDE-4 deletion constructs for their ability to support dsRNA-triggered gene silencing. These assays indicated a molecular requirement for a linker region and the second dsRNA-binding domain of RDE-4, with ancillary contributions to function from the C and N terminal domains. Second, we used mosaic... continue reading.

he journal Immunopharmacology and Immunotoxicology is devoted to preclinical and clinical studies about the regulatory effects of various agents on immunocompetent cells as well as the immunotoxicity exerted by xenobiotics and drugs. On these bases, the journal encompasses a broad range of pathologies (e.g., acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation and primary and secondary immunodeficiencies).In this framework, the journal will cover new emerging areas of science of broad interest, such as agricultural biotechnology; atherosclerosis; cytokine and growth factor regulation; dendritic cell therapy; food immunology and safety; forensic immunopathology; innate immunity regulation; microbial immunomodulators; mucosal immunity; drug development; psychoneuroimmunology; stem cell therapy; veterinary immunopathology; and vaccines. While articles related to purified extracts may be considered, research on crude botanical extracts are discouraged.Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, invited reviews, and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).Read More: http://informahealthcare.com/page/ipi/Description.

The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer. The IIAR will advance, protect and support throughout the world the ideals of freedom, peace, health, scientific knowledge, equality, welfare and mutual respect among communities in science and life.This site provides information on the aims and activities of the IIAR, including current cancer research projects and invitations for cooperation.The IIAR is supported by the three international peer-reviewed journals ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS which are also available online through the Stanford University HighWire Press.

The Indian Journal of Pharmacology (ISSN 0253-7613) is an official organ of the Indian Pharmacological Society. The first issue of the journal came out in 1969 and it was published Bimonthly. In 1997 it became a bimonthly publication. IJP publishes original research articles, reviews, research letters and correspondences.

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Inflammation Research (IR) publishes peer-reviewed papers on all aspects of inflammation and related fields including histopathology, immunological mechanisms, gene expression, mediators, experimental models, clinical investigations and the effect of drugs. Related fields are broadly defined and include for instance, allergy and asthma, shock, pain, joint damage, skin disease as well as clinical trials of relevant drugs.
Bibliographic Data
First published in 1969
Renamed in 1995
1 volume per year, 12 issues per volume
+ 2 supplements, in free sequence
Format: 21 x 27.9 cm
ISSN 1023-3830 (print)
ISSN 1420-908X (electronic)
 

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS).Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, and arthritic conditions. The journal has five main interest areas: Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress statesRheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugsGastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agentsNeuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and painNovel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs.Requirements for manuscripts on the pharmacological or inflammatory properties of, natural products are described in the editorial Inflammopharmacology Vol. 15, issue 5 or on the journal website: www.springer.com/10787.

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.The subject material appropriate for submission includes:• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.• Agents that activate genes or modify transcription and translation within the immune response.• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.• Production, function and regulation of cytokines and their receptors.• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. • Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system.• Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses.• The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc.• The Editors will be pleased to receive published books for possible independent review.Please Bookmark this URL: http://www.elsevier.com/locate/intimpThese Backfiles include Immunopharmacology and the International Journal of Immunopharmacology.